Skip to main content

CareDx to Report Second Quarter 2023 Financial Results

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will report financial results for the second quarter 2023 after market close on Tuesday, August 8th, 2023. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Individuals interested in listening to the conference call may do so by dialing 1-877-300-8521 for domestic callers or 1-412-317-6026 for international callers. Please reference Conference ID: 10181676. To listen to a live webcast, please visit the investor relations section of CareDx’s website at: investors.caredxinc.com.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  218.71
-3.32 (-1.50%)
AAPL  260.53
-2.24 (-0.85%)
AMD  238.77
+0.74 (0.31%)
BAC  51.20
-0.32 (-0.61%)
GOOG  255.21
+3.87 (1.54%)
META  737.47
+4.20 (0.57%)
MSFT  522.88
+5.23 (1.01%)
NVDA  182.95
+1.79 (0.99%)
ORCL  275.72
+0.57 (0.21%)
TSLA  440.68
-1.92 (-0.43%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.